Skip to main content
Caplight Logo









Synthesis Capital

Synthesis Capital

London, Englandsynthesis.capital

Overview

Synthesis Capital is a global food technology and alternative protein investor. The firm invests in companies that specialize in the alternative protein technology sector across the United Kingdom and the United States, integrating food technology and modern biotechnology to create innovative solutions that address key challenges in food production, sustainability, and nutrition .

Year Founded

2014

AUM

$300M

Portfolio Companies

14

Investments

Synthesis Capital investments
CompanyDateStageLead
Upside FoodsApr 2022Series CCo-investor
Redefine MeatJan 2022Series BLead
Culture BiosciencesDec 2025Series CCo-investor
TriplebarOct 2023Series ALead
Pow.BioApr 2025Series A ExtensionLead
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is Synthesis Capital based?

Synthesis Capital is headquartered in London, England, United Kingdom.

When was Synthesis Capital founded?

Synthesis Capital was founded in 2014.

How many portfolio companies does Synthesis Capital have?

Synthesis Capital has 14 portfolio companies in Caplight's dataset.

What are some companies in Synthesis Capital's portfolio?

Portfolio companies visible on Caplight include Upside Foods, Redefine Meat, Culture Biosciences, Triplebar, Pow.Bio.

What was Synthesis Capital's most recent investment shown here?

Synthesis Capital's most recent investment in this portfolio sample was in Culture Biosciences in 2025.

What sectors does Synthesis Capital focus on?

Synthesis Capital focuses on Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.

What company stages does Synthesis Capital focus on?

Synthesis Capital typically invests at the MultiStage stage.

What is Synthesis Capital's AUM?

Synthesis Capital's assets under management are estimated between $250.0M and $500.0M.

Firmographic Details

HeadquartersLondon, England
Year Founded2014
AUM$300M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?